Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossam Nada

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry|March 7, 2026
High-throughput fragment screening identifies a new small molecule scaffold that modulates TREM2 SignalingNatalie Fuchs, Farida El Gaamouch, Hossam Nada, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Discovery of a CHI3L1-Targeted Small Molecule Modulating Neuroinflammation in Alzheimer's Disease via DNA-Encoded Library (DEL) Screening <sup>†</sup>Baljit Kaur, Longfei Zhang, Hossam Nada, et al.
Archiv Der Pharmazie|October 3, 2025
c-KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future DirectionsShubham C Rivonker, Hossam Nada, Cho Jaemin, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Hit Identification of a Novel Quinazoline Sulfonamide as a Promising EphB3 Inhibitor: Design, Virtual Combinatorial Library, Synthesis, Biological Evaluation, and Docking Simulation StudiesKyeong Lee, Hossam Nada, Hyun Jung Byun, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Small Molecule Agonists of TREM2 Reprogram Microglia and Protect Synapses in Human Alzheimer's ModelsHossam Nada, Shaoren Yuan, Farida El Gaamouch, et al.
Biorxiv : the Preprint Server for Biology|December 8, 2025
High-Throughput Fragment Screening Identifies a New Small Molecule Scaffold that Modulates TREM2 SignalingNatalie Fuchs, Farida El Gaamouch, Hossam Nada, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
LigandForge: A Web Server for Structure-Guided De Novo Drug DesignHossam Nada, Levente Sipos-Szabó, Dávid Bajusz, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging TargetsHwayoung Lee, Ahmed Elkamhawy, Polina Rakhalskaya, et al.
International Journal of Molecular Sciences|June 10, 2023
Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure-Activity Relationship (SAR)Sreenivasulu Godesi, Joohan Lee, Hossam Nada, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2025
As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibitionSungwoo Cho, Farida El Gaamouch, Saurabh Upadhyay, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|March 7, 2026
High-throughput fragment screening identifies a new small molecule scaffold that modulates TREM2 SignalingNatalie Fuchs, Farida El Gaamouch, Hossam Nada, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Discovery of a CHI3L1-Targeted Small Molecule Modulating Neuroinflammation in Alzheimer's Disease via DNA-Encoded Library (DEL) Screening <sup>†</sup>Baljit Kaur, Longfei Zhang, Hossam Nada, et al.
Archiv Der Pharmazie|October 3, 2025
c-KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future DirectionsShubham C Rivonker, Hossam Nada, Cho Jaemin, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Hit Identification of a Novel Quinazoline Sulfonamide as a Promising EphB3 Inhibitor: Design, Virtual Combinatorial Library, Synthesis, Biological Evaluation, and Docking Simulation StudiesKyeong Lee, Hossam Nada, Hyun Jung Byun, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Small Molecule Agonists of TREM2 Reprogram Microglia and Protect Synapses in Human Alzheimer's ModelsHossam Nada, Shaoren Yuan, Farida El Gaamouch, et al.
Biorxiv : the Preprint Server for Biology|December 8, 2025
High-Throughput Fragment Screening Identifies a New Small Molecule Scaffold that Modulates TREM2 SignalingNatalie Fuchs, Farida El Gaamouch, Hossam Nada, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
LigandForge: A Web Server for Structure-Guided De Novo Drug DesignHossam Nada, Levente Sipos-Szabó, Dávid Bajusz, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging TargetsHwayoung Lee, Ahmed Elkamhawy, Polina Rakhalskaya, et al.
International Journal of Molecular Sciences|June 10, 2023
Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure-Activity Relationship (SAR)Sreenivasulu Godesi, Joohan Lee, Hossam Nada, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2025
As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibitionSungwoo Cho, Farida El Gaamouch, Saurabh Upadhyay, et al.
Pageof 8